Agache, Ioana <br/><br/>
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.  [electronic resource] 

 -  Allergy  05 2020 
 - 1043-1057 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review 
<br/><br/><label>ISSN: </label>1398-9995 
<br/><br/><label>Standard No.: </label>10.1111/all.14235  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Asthmatic Agents--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Asthma--drug therapy<br/>Biological Products--adverse effects<br/>Child<br/>Humans<br/>Omalizumab--adverse effects<br/>Quality of Life